192 related articles for article (PubMed ID: 34514723)
1. Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis.
Kitagawa K; Okada H; Miyazaki S; Funakoshi Y; Sanada Y; Chayahara N; Mayahara H; Fujii M
Cancer Med; 2021 Nov; 10(21):7525-7533. PubMed ID: 34514723
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Esophageal Cancer in a Patient with CMV Reactivation after Neoadjuvant Chemoradiation Therapy].
Megumi K; Okumura H; Shimonosono M; Ijichi T; Uchikado Y; Omoto I; Yo H; Kita Y; Uenosono Y; Arigami T; Mori S; Baba K; Ishigami S; Owaki T; Natsugoe S
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1307-9. PubMed ID: 26489581
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
4. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab.
Jain T; John J; Kotecha A; Deol A; Saliminia T; Revankar S; Chandrasekar P
Ann Hematol; 2016 Aug; 95(8):1323-7. PubMed ID: 27225264
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus reactivation in patients with multiple myeloma.
Hasegawa T; Aisa Y; Shimazaki K; Ito C; Nakazato T
Eur J Haematol; 2016 Jan; 96(1):78-82. PubMed ID: 25810117
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.
Morita-Hoshi Y; Heike Y; Kawakami M; Sugita T; Miura O; Kim SW; Mori SI; Fukuda T; Tanosaki R; Tobinai K; Takaue Y
Bone Marrow Transplant; 2008 Mar; 41(6):515-21. PubMed ID: 18026143
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Cytomegalovirus Reactivation in Lung Transplant Recipients.
Kwak SH; Lee SH; Park MS; Jeong SJ; Lee JG; Paik HC; Kim YS; Chang J; Kim SY
Lung; 2020 Oct; 198(5):829-838. PubMed ID: 32696252
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cytomegalovirus reactivation in patients with kidney disease under immunosuppressive therapy.
Iwatani Y; Amemiya N; Nokiba H; Yamazaki M; Sugiura H; Nitta K
Clin Exp Nephrol; 2022 Jan; 26(1):22-28. PubMed ID: 34342776
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Cytomegalovirus Reactivation after Chemoradiotherapy for Esophageal Cancer].
Adachi S; Niki T; Nishitani N; Horino J; Kawanaka S; Miyazaki Y; Higaki N; Ueshima S; Hayashida H; Ohnishi T; Nezu R
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1786-1788. PubMed ID: 33468829
[TBL] [Abstract][Full Text] [Related]
12. Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
Kimura SI; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Tamaki M; Kusuda M; Kameda K; Wada H; Sato M; Tanihara A; Nakasone H; Kako S; Kanda Y
Transpl Infect Dis; 2021 Feb; 23(1):e13460. PubMed ID: 32893940
[TBL] [Abstract][Full Text] [Related]
13. Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer.
Aizawa R; Matsumoto S; Uneno Y; Nishikawa Y; Ozaki Y; Mori Y; Kanai M; Ishida Y; Sakanaka K; Hiraoka M; Muto M
Jpn J Clin Oncol; 2017 Sep; 47(9):885-888. PubMed ID: 28591845
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
15. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
Yoshihara R; Komai T; Shoda H; Fujio K
Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
[TBL] [Abstract][Full Text] [Related]
16. Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
García-Bustos V; Salavert M; Blanes R; Cabañero D; Blanes M
Rev Esp Quimioter; 2022 Oct; 35 Suppl 3(Suppl 3):74-79. PubMed ID: 36285863
[TBL] [Abstract][Full Text] [Related]
17. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
[TBL] [Abstract][Full Text] [Related]
19. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.
Kuo CP; Wu CL; Ho HT; Chen CG; Liu SI; Lu YT
Clin Microbiol Infect; 2008 Mar; 14(3):221-7. PubMed ID: 18070129
[TBL] [Abstract][Full Text] [Related]
20. Impact of the radiotherapy combined with cisplatin plus paclitaxel chemotherapy on the immunologic functions in the patients with esophageal cancer.
Liu R; Zhang J; He C; Jiang Q; Liu J; Fan R
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1387-90. PubMed ID: 27592476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
